Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $161,194 - $264,876
-10,037 Closed
0 $0
Q4 2021

Jan 27, 2022

SELL
$41.2 - $73.6 $11,124 - $19,872
-270 Reduced 2.62%
10,037 $456,000
Q3 2021

Nov 12, 2021

SELL
$59.15 - $91.99 $6,210 - $9,658
-105 Reduced 1.01%
10,307 $653,000
Q2 2021

Jul 29, 2021

SELL
$63.02 - $95.11 $14,557 - $21,970
-231 Reduced 2.17%
10,412 $953,000
Q1 2021

May 14, 2021

BUY
$57.62 - $95.6 $83,606 - $138,715
1,451 Added 15.79%
10,643 $725,000
Q4 2020

Feb 12, 2021

BUY
$41.43 - $77.09 $380,824 - $708,611
9,192 New
9,192 $666,000
Q2 2019

Aug 12, 2019

SELL
$25.78 - $39.77 $494,073 - $762,192
-19,165 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$22.09 - $39.21 $423,354 - $751,459
19,165 New
19,165 $604,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.37B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.